Alexandra M G Brunasso, Martin Laimer, Cesare Massone. Show Affiliations »
Abstract
Mesh: See more » AbataceptAdultAnti-Inflammatory Agents/adverse effectsAntibodies, Monoclonal/adverse effectsAntibodies, Monoclonal, HumanizedAntirheumatic Agents/adverse effectsArthritis, Rheumatoid/drug therapyBiological Products/adverse effectsColitis, Ulcerative/drug therapyEtanerceptFemaleHumansImmunoconjugates/adverse effectsImmunoglobulin G/adverse effectsInfliximabMaleMiddle AgedPsoriasis/chemically inducedPsoriasis/pathologyPyoderma Gangrenosum/chemically inducedPyoderma Gangrenosum/drug therapyPyoderma Gangrenosum/pathologyReceptors, Tumor Necrosis Factor
Substances: See more » Anti-Inflammatory AgentsAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntirheumatic AgentsBiological ProductsImmunoconjugatesImmunoglobulin GReceptors, Tumor Necrosis FactorAbataceptInfliximabEtanerceptefalizumab
Year: 2010 PMID: 20169304 DOI: 10.2340/00015555-0777
Source DB: PubMed Journal: Acta Derm Venereol ISSN: 0001-5555 Impact factor: 4.437